Shandong Sinobioway Biomedicine Co., Ltd. (002581.SZ)
CNY 12.4
(-0.08%)
CNY 12.4
(-0.08%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 429.79 Million | 357.08 Million | 402.71 Million | 276.83 Million | 567.63 Million | 664.59 Million |
| Cost of Revenue | 93.28 Million | 76.21 Million | 85.83 Million | 54.32 Million | 74.14 Million | 98.55 Million |
| Gross Profit | 336.5 Million | 280.86 Million | 316.87 Million | 222.5 Million | 493.49 Million | 566.03 Million |
| Operating Expenses | 629.85 Million | 448.27 Million | 508.12 Million | 460.37 Million | 582.06 Million | 560.31 Million |
| Selling, General and Administrative Expenses | 405.48 Million | 375.29 Million | 434.66 Million | 379.61 Million | 495.53 Million | 483.86 Million |
| Research and Development Expenses | 59.79 Million | 27.28 Million | 38.43 Million | 49.29 Million | 54.65 Million | 45.95 Million |
| Other Expenses | 144.31 Million | 45.68 Million | 35.02 Million | 31.46 Million | 31.87 Million | 14.48 Million |
| Cost and Expenses | 723.14 Million | 524.48 Million | 593.95 Million | 514.69 Million | 656.2 Million | 658.86 Million |
| Operating Income | -293.35 Million | 33.67 Million | 273.08 Million | -237.86 Million | 105.86 Million | -87.24 Million |
| Interest Expense | 8.63 Million | 9.41 Million | 6.87 Million | 25.42 Million | 40.85 Million | 78.15 Million |
| Income Tax Expense | 8.88 Million | 13.59 Million | -90.78 Thousand | -3.58 Million | 3.68 Million | 9.21 Million |
| Earnings before Tax | -313.24 Million | 12.72 Million | 278.59 Million | -201.76 Million | 76.76 Million | -89.01 Million |
| Net Income | -332.45 Million | -868.19 Thousand | 271 Million | -198.17 Million | 63.38 Million | -95.78 Million |
| Earnings Per Share Basic | -0.50 | -0.00 | 0.41 | -0.30 | 0.10 | -0.15 |
| Earnings Per Share Diluted | -0.50 | -0.00 | 0.41 | -0.30 | 0.10 | -0.15 |
| Weighted Average Shares Outstanding | 659.77 Million | 659.73 Million | 659.73 Million | 659.73 Million | 659.73 Million | 659.58 Million |
| Weighted Average Shares Outstanding (Diluted) | 659.77 Million | 659.73 Million | 659.73 Million | 659.73 Million | 659.73 Million | 659.58 Million |
| Gross Margin | 0.78 | 0.79 | 0.79 | 0.80 | 0.87 | 0.85 |
| EBIT Margin | 0.14 | 0.30 | 0.88 | -0.22 | 0.29 | 0.36 |
| Profit Margin | -0.77 | -0.00 | 0.67 | -0.72 | 0.11 | -0.14 |
| EBITDA | 58.05 Million | 106.06 Million | 351.24 Million | -116.68 Million | 163.85 Million | 30.24 Million |
| Earnings Before Tax Margin | -0.68 | 0.09 | 0.68 | -0.86 | 0.19 | -0.13 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 102.31 Million | 126.97 Million | 83.8 Million | 91.44 Million | 429.79 Million | 129.18 Million |
| Cost of Revenue | 21.4 Million | 24.13 Million | 16.64 Million | 19.64 Million | 83.39 Million | 23.87 Million |
| Gross Profit | 80.9 Million | 102.84 Million | 67.15 Million | 71.8 Million | 346.39 Million | 105.3 Million |
| Operating Expenses | 87.41 Million | 105.68 Million | 89.7 Million | 160.17 Million | 513.06 Million | 115.36 Million |
| Selling, General and Administrative Expenses | 81.65 Million | 86.01 Million | 82.23 Million | 90.05 Million | - | 130.99 Million |
| Research and Development Expenses | 5.75 Million | 5.79 Million | 6.2 Million | 21.09 Million | - | 9.95 Million |
| Other Expenses | - | -175.55 Thousand | 1.1 Million | -18.32 Million | -20.26 Million | -977.53 Thousand |
| Cost and Expenses | 108.82 Million | 129.82 Million | 106.35 Million | 179.81 Million | 596.45 Million | 139.24 Million |
| Operating Income | -6.5 Million | 3.69 Million | -27.94 Million | -337.97 Million | -293.35 Million | 95.08 Million |
| Interest Expense | - | - | - | 8.63 Million | 8.63 Million | -5.6 Million |
| Income Tax Expense | 2.24 Million | 1.28 Million | 208.29 Thousand | 4.72 Million | 8.88 Million | 4.72 Million |
| Earnings before Tax | 51.06 Million | 3.52 Million | -26.84 Million | -355.93 Million | -313.24 Million | 94.1 Million |
| Net Income | 44.24 Million | -1.91 Million | -27.7 Million | -362.17 Million | -332.45 Million | 83.47 Million |
| Earnings Per Share Basic | 0.07 | -0.00 | -0.04 | -0.55 | - | 0.13 |
| Earnings Per Share Diluted | 0.07 | -0.00 | -0.04 | -0.55 | - | 0.13 |
| Weighted Average Shares Outstanding | 659.73 Million | 659.73 Million | 659.62 Million | 658.19 Million | 659.77 Million | 659.73 Million |
| Weighted Average Shares Outstanding (Diluted) | 659.73 Million | 659.73 Million | 659.62 Million | 658.19 Million | 659.77 Million | 659.73 Million |
| Gross Margin | 0.79 | 0.81 | 0.80 | 0.79 | 0.81 | 0.82 |
| EBIT Margin | 0.50 | 0.03 | -0.28 | -0.76 | - | 0.69 |
| Profit Margin | 0.43 | -0.02 | -0.33 | -3.96 | -0.77 | 0.65 |
| EBITDA | 51.06 Million | 4.04 Million | -23.61 Million | -69.12 Million | - | 89.3 Million |
| Earnings Before Tax Margin | -0.06 | 0.03 | -0.33 | -3.70 | -0.68 | 0.74 |
ORES
QCRH
3490
MLP
TOST
SHG